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ABSTRACT The a2-globin gene of an individual with a-thalassemia associated with the absence of a2 mRNA was cloned in bacteriophage. This mutant globin gene was normally active in transcription in vitro. The DNA sequence of the gene, however, revealed a pentanucleotide deletion within the 5' splice junction of the first intervening sequence. Following the G of the invariant G-T dinucleotide normally located within such junctions, a deletion of T-G-A-G-G was found. No other sequence abnormalities within the mutant gene were present. We speculate therefore that this deletion within the splice junction is the primary genetic defect in this individual with thalassemia and that loss of a functional splice juction results in failure of stable mRNA formation. Most eukaryotic genes are mosaic structures assembled from coding and intervening sequences (1, 2) . In the case of mammalian globin genes two intervening sequences, situated in homologous positions in a-globin-like and /3-globin-like loci, are normally present (3, 4) . Within the nucleus ofdeveloping erythroid cells these sequences are transcribed as part of globin mRNA precursors that are subsequently processed into mature mRNA by a series of cleavage-ligation reactions (splicing events) (5-7). The nucleotide sequences of numerous cloned eukaryotic genes reveal striking similarities at the boundaries of coding and intervening sequences (splice junctions). These may be accommodated by consensus sequences of the general type A-G-G-T-A-A-G for the 5'-donor sites and T-T-N-C-A-G-G for the 3' acceptor sites (8, 9) . Almost without exception, intervening sequences have the dinucleotide G-T at their 5' ends and A-G at their 3' ends [the Chambon rule (8) ]. Participation of ubiquitous nuclear U1 RNAs in appropriate recognition of these sites is suggested by their complementarity with sequences found at these splice junctions (10, 11) . Although the effects of specific mutations in these junctional sequences have not been studied to date, analyses of specially constructed viral DNA mutants and recombinants, often bearing globin gene sequences and their splice junctions, have suggested a requirement for at least one splicing event in the formation of stable cytoplasmic mRNAs (12) (13) (14) (15) .
Genetic disorders of human hemoglobin synthesis, the thalassemias (16) , provide a reservoir of naturally occurring mutant genes that may facilitate study ofthese complex cellular events. For example, in 83+-thalassemias, conditions in which mature f3-globin mRNA and 83-globin polypeptide are quantitatively reduced, the processing of /3-globin RNA precursors in several patients appears inefficient (17, 18) . In selected cases, abnormal ,8-globin mRNAs that may resemble processing intermediates are detectable (18) . Furthermore, in one instance, nucleotide sequencing of a 83-globin gene isolated from an individual with /3+-thalassemia identified a single base substitution within the body ofthe first intervening sequence (IVS-1) (19) . This change could generate a new splicing signal and thereby alter the usual pathway of ,B-globin RNA processing.
Genetically defective globin genes that direct the production of no stable mRNA species may be especially useful in exploration ofmRNA biogenesis. Our recent progress in defining the expression ofthe human a-globin genes (20) suggested for study a mutant locus with the desired phenotype. Whereas normal humans have stable RNA directed by both the 5'(a2) and 3'(al) structural genes of the duplicated a-gene complex (20) (21) (22) , some individuals with a-thalassemia have a profound (if not total) deficiency of a2 mRNA in the face of a grossly normal agene region as defined by restriction enzyme mapping (23) . We have cloned the putative mutant a2-globin gene from one such individual, and we demonstrate here that it is specifically altered at a coding region-intervening sequence boundary. This lesion, a naturally occurring mutation ofa splice junction, raises questions regarding the processing ofprecursor mRNAs and the generation of stable mRNAs.
MATERIALS AND METHODS Patient Material. Lymphocyte DNA of an Italian patient with a-thalassemia of the Hb H disease type was prepared as before (23) . By restriction mapping with EcoRI digestion, this individual has the genotype 22.5 kb/2.6 kb (kb, kilobase) (23). On one chromosome, two a loci (one of the a2 and one of the al type) are present in the normal arrangement. On the other chromosome, a partially deleted al gene is found (24) .
Cloning of the a-Globin Gene Complex. The National Institutes of Health guidelines for recombinant DNA research were followed. DNA fragments greater than 9 kb in length after digestion with EcoRI and BamHI were prepared by sucrose gradient centrifugation and cloned in phage arms isolated from A bacteriophage Charon 30 (25) . Recombinant phages were screened by the Benton-Davis procedure (26), using probe prepared from a 1.6-kb fragment isolated from normal a gene subclones (22) after Pst I digestion. From a positive phage containing the desired 14-kb EcoRI/BamHI fragment (21, 22) , the a2 gene was removed from the phage DNA in a 4.3-kb fragment after Sac I digestion and then subcloned after Pst I digestion in plasmid pBR322.
In Vitro Transcription. Assays were performed precisely as described by Manley et al. (27) .
DNA Sequence Analysis. DNA nucleotide sequence was determined by the method of Maxam and Gilbert (28, 29) . The strategy was that previously used by us in the analysis of an al gene (30) . Critical regions were examined on complementary strands.
Gene Mapping. Restriction enzyme analyses ofcellular DNA were performed as before (31) except dextran sulfate was added to the hybridization mixtures (32 (33) of the Berk-Sharp procedure (34) was performed as described (20 
RESULTS
The duplicated a-globin gene complex was cloned intact as a 14-kb EcoRI/BamHI fragment from the DNA of an Italian individual with "nondeletion" a-thalassemia (23, 35) . In this entity a normal-appearing a-globin gene complex is present, as determined by restriction enzyme mapping, yet hematologic findings indicate that a mRNA sufficient for only a single a gene is found in erythroid cells. In the patient studied here S1 nuclease mapping previously demonstrated that the abundance of a2 mRNA was less than 3% that of al-mRNA in peripheral blood erythroid cells (20) . Because (27, 36) . Transcription is dependent on DNA sequences 5' to the gene, especially within the T-A-T-A-A-G box (4, 37, 38) , and is markedly reduced from nonfunctional pseudogenes containing altered sequences in that region (4, 39) . Cloned normal human a-globin genes are active in vitro in the transcription system of Manley et al. (4, 27) . The cloned a2 gene isolated from the a-thalassemic individual was indistinguishable from normal in its capacity to direct synthesis of appropriate RNA species in vitro (Fig. 1) .We conclude that this gene contains a promoter active in the heterologous system. In view of this result, we directed attention to the body of the gene itself.
DNA Sequence of the Mutant a2-Globin Gene. The nucleotide sequence of the presumed mutant a2 gene is displayed in Fig. 2 . For comparison we employed the sequence of a normal a2-globin gene reported by Liebhaber et al. (40) . In addition, specific discrepancies between their sequence and our mutant gene were further analyzed in our work by direct sequence analysis of the normal a2 gene cloned by Lauer et al. (22) . The only sequence abnormality ofthe mutant gene resided at the beginning of the first intervening sequence (IVS-1). Following the G of the invariant G-T contained within the donor splice site, a pentanucleotide deletion (T-G-A-G-G) was found (Figs. 2-4 ). In the normal sequence this region is particularly rich in short direct repeats (Fig. 4 ) that appear to contribute to the production of limited deletions (41) . The pentanucleotide deletion in the mutant gene radically altered the junction of the coding region and IVS-1. The resulting junctional sequences do not conform to the Chambon rule (8) or to consensus sequences of known donor splice sites (8, 9) .
We carefully examined the entire mutant gene for additional sequence abnormalities. None were found. Several apparent Restriction enzyme-digested plasmid DNAs were transcribed at a concentration of 50 ug/ml in the system of Manley et al. (27) . Samples were glyoxylated, electrophoresed in agarose, and subjected to autoradiography. Plasmids containing the normal a2 gene (22) and the mutant a2 gene (lanes nl and Thal, respectively) were digested with Pst I. The expected length of the transcribed RNA from these truncated plasmids is shown below (nt, nucleotides). Plasmid DNA containing the adenovirus Bal I E fragment digested with BamHI (27) (22) were identical. The differences between our sequence and that of Liebhaber et al. (40) 
-G-C-G-C-G-G-C-T-T-G-G-C-C rather than G-G-C-I-G-C-G-G-G-C--T-G-G-G-C-C as shown above.
We have examined this region on complementary strands in both mutant and normal a2 genes and found the latter sequence. Furthermore, the sequence C-T-T-G-G rather than C-C-T-G-G is inconsistent with the presence of aBstNI restriction site previously identified in the a2 gene cloned by Lauer et al. (22) and verified in our direct sequence analysis. tural locus is removed (22) . The cloned a gene complex of our patient as isolated in phage was not rearranged as shown by restriction enzyme digestions with HindIII, Hpa I, and Sac I (not shown). Although this excluded major rearrangements of the type described previously (22) , small deletions or insertions would not be detected by such analysis. Fortuitously, the pentanucleotide deletion (T-G-A-G-G) in the mutant gene removed a recognition site for the enzyme Hph I (G-G-T-G-A) (42) located with the splice junction of IVS-1 (see Fig. 4 ). Deletion of this recognition site in the a2 gene would generate a novel DNA fragment in the uncloned mutant-DNA upon digestion with Hph I, 0.3 kb larger than the corresponding normal a2 gene fragment (Fig. 5) . Gene mapping of the uncloned cellular DNA revealed the predicted novel fragment (Fig. 5) , thereby demonstrating that the Hph I site was altered prior to cloning and amplification of sequences in phage DNA. Furthermore, the pattern of a-specific DNA fragments upon Hph I digestiorr was identical for the uncloned DNA and the phage DNA containing the mutant a complex (not shown).
Gene mapping with Hph I offers a convenient means for investigating potential molecular heterogeneity in this form of a-G A+G C+T C thalassemia. In an individual of Asian background with nondeletion a-thalassemia, also associated with deficiency of a2 mRNA, the hybridization pattern after digestion with Hph I was entirely normal (not shown). We conclude that a different molecular defect, either within the a2 gene or affecting its expression, exists in the DNA of this unrelated individual. The molecular basis of this condition is heterogeneous.
Absence ofAbnormal a2 mRNA Species. Previously a probe directed at the 3'-untranslated region of the a sequence was used to distinguish and quantitate the RNA products ofthe du- NatL Acad. Sci. USA 78 (1981) periments in which the 3' untranslated portion of the mRNA was used as a marker for a2 mRNA, we condlude that no a2 mRNA, either unspliced or abnormally spliced at IVS-1, was present in the stable erythroid cell RNA of the patient. Studies of others involving cloned f3-globin genes from 13-thalassemic individuals lend further support to the concept that abnormalities within one intervening sequence may lead to a quantitative deficiency of RNA, such as that characteristic of thalassemia syndromes (45, 46) . In the 13-globin gene of a j+ thalassemic individual a single nucleotide substitution within the body of IVS-1 has been detected (19) . In another gene isolated from a patient with 13-thalassemia a substitution for the G of the G-T dinucleotide at the beginning of IVS-2 was observed (T. Maniatis, personal communication). In contrast with the leNormal a-Thalassemnia sion described here, these single base substitutions in intervening sequences may alter the efficiency of precursor mRNA processing more than its fidelity, as suggested by a mutation of an intervening sequence junction in a yeast tRNA gene (47 
